In an attempt to accelerate the pace of HIV vaccine development, the Bill & Melinda Gates Foundation has awarded 16 grants totaling $287 million over 5 years to create an international network of collaborative research consortia. These consortia will bring together more than 165 investigators from 19 countries to tackle various challenges in HIV vaccine discovery and development.
“With 11 000 new HIV infections occurring every day, a preventive vaccine is our best long-term hope for controlling the AIDS epidemic” said Nicholas Hellmann, MD, acting director of the Gates Foundation's HIV, TB, and Reproductive Health Program.
Hampton T. HIV Vaccine Research Gets $287 Million Boost. JAMA. 2006;296(7):756. doi:10.1001/jama.296.7.756